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OBJECTIVE—Chronic low-grade inﬂammation is a feature of
obesity and is postulated to be causal in the development of
insulin resistance and type 2 diabetes. The aim of this study was
to assess whether overfeeding induces peripheral insulin
resistance in lean and overweight humans, and, if so, whether
it is associated with increased systemic and adipose tissue
inﬂammation.
RESEARCH DESIGN AND METHODS—Thirty-six healthy
individuals undertook 28 days of overfeeding by 1,250 kcal/day
(45% fat). Weight, body composition, insulin sensitivity (hyper-
insulinemic-euglycemic clamp), serum and gene expression of
inﬂammation markers, immune cell activation, fat cell size,
macrophage and T-cell numbers in abdominal subcutaneous
adipose tissue (ﬂow cytometry and immunohistochemistry) were
assessed at baseline and after 28 days.
RESULTS—Subjects gained 2.7  1.6 kg (P  0.001) and
increased fat mass by 1.1  1.6% (P  0.001). Insulin sensitivity
decreased by 11% from 54.6  18.7 to 48.9  15.7 mol/(kg of
FFM)/min (P  0.01). There was a signiﬁcant increase in circu-
lating C-reactive protein (P  0.002) and monocyte chemoattrac-
tant protein-1 (P  0.01), but no change in interleukin-6 and
intercellular adhesion molecule-1. There were no changes in fat
cell size, the number of adipose tissue macrophages or T-cells, or
inﬂammatory gene expression and no change in circulating
immune cell number or expression of their surface activation
markers after overfeeding.
CONCLUSIONS—Weight gain-induced insulin resistance was
observed in the absence of a signiﬁcant inﬂammatory state,
suggesting that inﬂammation in subcutaneous adipose tissue
occurs subsequent to peripheral insulin resistance in humans.
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C
hronic low-level inﬂammation may be a pivotal
link between obesity, insulin resistance, and
type 2 diabetes (1). Studies performed in mouse
models of obesity and in humans have shown
increases in circulating proinﬂammatory mediators includ-
ing C-reactive protein (CRP), monocyte chemoattractant
protein-1 (MCP-1), and interleukin-6 (IL-6) (2–4). More-
over, obesity is associated with increased macrophage
accumulation in adipose tissue with the majority of mac-
rophages being located in crownlike structures, where
aggregates of macrophages surround dead adipocytes (5).
Importantly, cytokines derived from adipose tissue mac-
rophages inhibit the insulin signaling cascade and can
contribute to systemic insulin resistance in humans (6–8).
However, whether adipose tissue macrophage accumula-
tion causes insulin resistance in obese humans remains
unclear.
Obesity is associated not only with an increase in the
total number of macrophages in adipose tissue (9) but also
with a change in their activation state, from the alternative
M2 to classical M1 phenotype. M1 macrophages are typi-
cally proinﬂammatory and release tumor necrosis factor,
IL-6, and MCP-1, whereas M2 macrophages express an
anti-inﬂammatory gene proﬁle, characterized by higher
expression of CD206 and IL-10 (10). Recent data has
shown that M1 phenotype macrophages are 4-fold in-
creased in subcutaneous adipose tissue from morbidly
obese individuals as compared with lean individuals, with
surgery-induced weight loss resulting in a twofold de-
crease in the M1/M2 ratio due to a concomitant decrease in
M1 and increase in M2 macrophages (11). Importantly,
both the number of M1 macrophages and the M1/M2 ratio
have been shown to correlate with whole-body insulin
sensitivity (12). There have been no studies examining the
effects of moderate weight gain on M1/M2 phenotype in
humans.
T-cells, with their activation and hyperpolarization into
a proinﬂammatory T-helper 1 phenotype, may play an
important role in initiating and perpetuating adipose tissue
inﬂammation (13–16). In mouse models of obesity, T-cell
inﬁltration in adipose tissue is observed after 5 weeks of
high-fat diet (HFD) in conjunction with the induction of
insulin resistance (14). Despite evidence linking T-cell
inﬁltration to adipose tissue in animal models of obesity,
there have been no studies examining T-cells in adipose
tissue during overfeeding in humans. Furthermore, there is
no data to clarify whether circulating immune cell activa-
tion is an early change contributing to chronic inﬂamma-
tion and development of insulin resistance or whether
insulin resistance precedes immune activation.
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ORIGINAL ARTICLE
2164 DIABETES, VOL. 59, SEPTEMBER 2010 diabetes.diabetesjournals.orgThe aims of this study were to investigate 1) whether
short-term high-fat overfeeding and modest weight gain
affects insulin sensitivity and systemic low-grade inﬂam-
mation, immune cell counts and activation, and inﬂamma-
tory gene expression and 2) the relationships between
these variables. Our data suggest that modest weight gain
and peripheral insulin resistance induced by overfeeding
occurs prior to subcutaneous adipose tissue macrophage
inﬁltration and induction of a signiﬁcant inﬂammatory
state in humans.
RESEARCH DESIGN AND METHODS
Subjects and study design. The study design and proto-
col is described in detail elsewhere (17). Brieﬂy, healthy
normolipedemic, nondiabetic individuals completed 28
days of an overfeeding protocol outlined below. The
cohort consisted of 19 females (5 postmenopausal) and 17
males, mean age 37 years (21–59 years); 16 subjects
reported a family history of type 2 diabetes and 20 had no
diabetic relatives. Subjects were not taking any medica-
tions. All subjects signed informed consent prior to start-
ing the study. This study was approved by the Human
Research and Ethics Committee from St. Vincent’s Hospi-
tal and is registered as a clinical trial at clinicaltrials.gov,
registration number NCT00562393.
Complete 3-day food intakes were provided before
metabolic testing visits at baseline and study end. At
baseline, this was at calculated energy requirements (17),
with a nutrient composition of 30% fat, 15% protein, and
55% carbohydrate. During overfeeding, this was at 1,250
kcal/day above baseline energy requirements with a nutri-
ent composition of 45% fat, 15% protein, and 40% carbohy-
drate. During the rest of the overfeeding phase (days
3–25), subjects consumed their regular diets and were
provided with high-fat snacks (1,250 kcal) (17). Average
reported energy intake during this phase increased from
2,250  480 to 3,250  480 kcal/day, and the contribution
of fat from 35  7 at baseline to 46  4%. Weight gain and
compliance were monitored weekly by the research nurse
and dietitian.
Metabolic testing at baseline and after 28 days of
overfeeding. All metabolic tests were conducted at the
Clinical Research Facility at the Garvan Institute of Med-
ical Research after a 12-h overnight fast. Weight was
measured in a hospital gown after voiding. Height, blood
pressure, and waist and hip circumference were also
measured. Fasting blood samples were drawn and insulin
sensitivity was assessed by a 2-h hyperinsulinemic-eugly-
cemic clamp (60 mU/m
2 body surface  min
1), as previ-
ously described (18). Steady-state glucose infusion rate
(GIR) between 90 and 120 min was averaged and normal-
ized for the fat free mass (FFM). Body composition was
measured by dual-energy X-ray absorptiometry (Lunar
DPX GELunar, Lunar Corp., Madison, WI). Liver fat con-
tent was measured by computed tomography as previously
described (17). A needle biopsy of periumbilical subcuta-
neous adipose tissue was performed immediately prior to
the clamp (19,20), to obtain 300 mg of tissue which was
processed as described below. The same procedures were
repeated on day 28. An additional blood sample for CRP
was taken at 3 days of overfeeding.
Immunohistochemistry and fat cell size. The biopsies
were processed as previously described (9,21). We used
antibodies targeted to macrophages (HAM56; Dako Cyto-
mation, Trappes, France), M1 (CD40; R&D Systems, Min-
neapolis, MN) and M2 phenotype macrophages (CD206;
R&D Systems, Minneapolis, MN), and T-lymphocytes
(CD3; Neomarker Microm, Francheville France) (n  33).
Immunohistochemical detection was performed with the
avidin–biotin–peroxidase method, and slides were coun-
terstained with Mayer’s hematoxylin. Positively labeled
cells were identiﬁed by careful visual examination of the
slides with increasing grades of magniﬁcation and were
counted in ten randomly chosen areas at 	40 magniﬁca-
tion. The number of positively labeled cells was expressed
as a percentage per 100 adipocytes (i.e., number of posi-
tive stained cells/number of adipocytes 	 100). In addi-
tion, adipocyte diameter measurement was performed
blindly and for at least two ﬁelds of view. The mean
diameter was calculated from an average of 400 cells per
sample (17).
Immune cell preparation and ﬂow cytometry analy-
sis. Using standard protocol, fresh whole blood was
stained with ﬂuorochrome-conjugated antibodies to vari-
ous cell surface markers purchased from BD Biosciences
(San Diego, CA) in a subset of 24 individuals pre- and
post-intervention. All analyses were performed on a BD
FACSCaliburTM (BD Biosciences, San Diego, CA) with an
excitation laser line argon (488 nm) and red diode (635
nm) and running CellQuest software (version 3.3 from BD
Biosciences). Data analysis software FlowJo version 7
from TreeStar Inc. was used. For comparative quantiﬁca-
tion of surface activation marker expression, the mean
ﬂuorescence intensity (MFI) of the marker was divided by
the MFI of the unstained control to give relative MFI
(rMFI). For quantiﬁcation of Th1/Th2 cells, we used intra-
cellular cytokine staining for the key cytokines interfer-
on-
 (for Th1) and IL-4 (for Th2) (BD Bioscience
Pharmingen, San Diego, CA). Brieﬂy, peripheral blood
mononuclear cells were activated with phorbol myristic
acid (160 ng/ml) and Ionomycin (1,000 ng/ml) for4ha t
37°C in the presence of GolgiPlug (BD Bioscience, San
Diego, CA), allowing the identiﬁcation of T-helper cell
subsets. After surface staining for CD4
 and CD8
, cells
were permeabilized using BD Cytoﬁx/Cytoperm reagents
(BD Bioscience Pharmingen, San Diego, CA), stained for
intracellular cytokines, and analyzed immediately by ﬂow
cytometry.
Flow cytometry of adipose tissue stromovascular
fraction. Fresh periumbilical subcutaneous adipose tis-
sue (150 mg) was placed in a prewarmed buffer (10
mmol/l CaCl2, 6 mmol/l Na2HPO4,125 mmol/l HEPES, 12
mmol/l MgSO4, 4 mmol/l NaH2PO4, 1.2M NaCl, 60 mmol/l
KCl, 3 g BSA, and 0.09 g D-glucose in 100 ml H2O, pH 7.4,
37°C) and digested with collagenase type IV at 37°C.
Stromovascular fraction was separated from mature adi-
pocytes by centrifugation (1,200 rpm), washed twice with
ice-cold PBS, and stained to quantify cell subsets and
activation markers (22) by ﬂow cytometry. Preadipocytes/
CD34 progenitor cells were identiﬁed by staining for
stem cell marker CD34 and by excluding CD31/endothe-
lial cells. Macrophages were detected by CD14 staining.
Results are expressed as a percentage of all viable cells,
and CD11b expression on macrophages by rMFI.
RNA extraction and quantitative real-time PCR. Total
RNA was extracted from 100–150 mg adipose tissue using
TRIzol reagent (Invitrogen, Carlsbad, CA). The integrity
and concentration of RNA was assessed by spectropho-
tometry (Nanodrop, 2000, Thermoline). cDNA was synthe-
sized using Omniscript RT kit (Qiagen, GmbH, Germany)
and Recombinant RNAsin RNase inhibitor (Promega, Mad-
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yses, we chose a range of macrophage inﬂammation
related genes and used gene-speciﬁc primer probes from
Taqman (CD68, CD11c, CD206, MCP-1, IL-10, CD40, and
Arginase 1) and Taqman universal PCR master mix (Ap-
plied Biosystems, Darmstadt, Germany). The samples
were run in duplicate on an ABI Prism 7,900 system
(Applied Biosystems, Darmstadt, Germany) with internal
negative controls and a standard curve. The CT value for
each sample was normalized to the CT value of -actin,
which was not different between days 0 and 28. CD40 and
Arginase 1 expression were below detection.
Biochemical variables. Plasma glucose was determined
by the glucose oxidase method (Glucose analyzer 2,300
STAT PLUS 230V, YSI, Inc., Yellow Springs, OH). Serum
insulin was measured by radioimmunoassay (Linco, St.
Charles, MO). Serum total cholesterol, HDL cholesterol,
and triglycerides were determined spectrophotometrically
at 490 nm by enzymatic colorimetry (Roche, Basel, Swit-
zerland). High-sensitivity CRP was measured using a Beck-
man Coulter Synchron LX system Chemistry Analyser,
with reagents and calibrators supplied by Beckman
Coulter Inc. (Sydney, Australia). CV was 3.7% at a level of
4.9 mg/l, and the sensitivity was 0.2 mg/l. IL-6, MCP-1, and
soluble intercellular adhesion molecule (sICAM)-1 were
measured using commercial high-sensitivity ELISAs (R&D
Systems, Minneapolis MN). The observed CVs were 7%,
10%, and 10%, respectively.
Statistical analysis. Analyses were performed using Sta-
tistical Package for Social Sciences, version 15.0. Because
no differences were detected for any markers of inﬂam-
mation at baseline or in response to overfeeding between
individuals with and without a family history of diabetes,
these groups were combined for all analyses. Comparisons
between time points were performed using the paired t
test (for normally distributed data) and the nonparametric
Sign test (for skewed data). Correlations between vari-
ables were expressed as Pearson or Spearman correlation
coefﬁcients. P  0.05 was considered signiﬁcant, and data
are presented as mean  SD unless otherwise stated.
RESULTS
Clinical measures. Anthropometric and metabolic mea-
sures of the 36 participants studied at baseline and after 28
days of overfeeding are summarized in Table 1. Weight
gain was signiﬁcant, with an increase of 2.7  1.6 kg
(3.6%, P  0.001). Similarly, BMI, waist circumference, %
body fat, and liver fat were signiﬁcantly increased (all P 
0.001). Fat cell size did not change. Fasting insulin and
glucose increased (P  0.01), and insulin sensitivity de-
creased by 11% (P  0.01).
Serum inﬂammation markers. In response to 28 days of
overfeeding, we observed signiﬁcant increases in CRP
(P  0.003) and MCP-1 (P  0.005), but no change in IL-6
or sICAM-1 (Fig. 1). CRP levels showed a similar increase
after 3 days (P  0.008, data not shown). At baseline, CRP
correlated with BMI, % fat, and fat cell size (all r  0.6, P 
0.001) and IL-6 correlated positively with % fat mass and
increased liver fat (both r  0.4, P  0.04), but neither
inﬂammatory marker correlated with baseline GIR/FFM.
No associations were seen between levels of MCP-1 or
sICAM-1 and any measure of adiposity, although MCP-1
levels were negatively correlated with GIR/FFM (r 
0.38, P  0.03). At baseline, MCP-1 levels were corre-
lated with the number of HAM56 labeled cells (r  0.38,
P  0.04) and IL-6 levels were associated with increased
liver fat (r  0.41, P  0.02). There were no relationships
between changes in markers of inﬂammation and adipos-
ity or insulin sensitivity in response to overfeeding.
Subcutaneous adipose tissue gene expression. Macro-
phage and inﬂammation related genes, CD68, CD40,
CD206, CD11c, MCP-1, and IL-10, were examined. We
found no signiﬁcant differences between baseline and 28
days after overfeeding for any genes measured (data not
shown). Furthermore, there were no baseline or change
from baseline associations between gene expression and
measures of adiposity and insulin sensitivity.
Immunohistochemistry. HAM56 labeled macrophages
were mostly dispersed in the parenchyma and few crown-
like structures were seen at baseline or 28 days after
overfeeding (Fig. 2). As in a previous study (11), CD40 and
CD206 were used as markers of M1 and M2 macrophages,
respectively. We found a trend toward a higher M1/M2
ratio at 28 days of overfeeding (P  0.05), although there
were no statistical differences in the absolute numbers of
CD40 (P  0.36) and CD206 (P  0.42) labeled cells (Fig.
2). There was little evidence of CD3 labeled T-cells at
baseline or 28 days after overfeeding, with CD3 cells
only observed in 2/66 slides. At baseline, CD40 was related
to liver fat (r  0.4, P  0.03) but no other markers of
adiposity. There were no other associations between mac-
rophage markers and adiposity or insulin resistance at
baseline or in response to overfeeding (data not shown).
Stromovascular fraction of adipose tissue. The cellu-
lar content of the stromovascular fraction of periumbilical
subcutaneous adipose tissue was investigated by ﬂow
cytometry. The number of macrophages, preadipocytes,
and endothelial cells were unchanged after 28 days of
overfeeding (Fig. 3). Similarly, CD11b (MAC-1) expression
on macrophages did not change. At baseline, the number
of macrophages in subcutaneous adipose tissue was sig-
niﬁcantly correlated with central fat mass (r  0.36, P 
0.02), liver fat (r  0.53, P  0.002), and insulin resistance
(r  0.37, P  0.001). Also, CD11b expression on
macrophages correlated positively with MCP-1 levels at
baseline (r  0.48, P  0.01).
TABLE 1
Anthropometric and metabolic measures of 36 subjects at base-
line and after 28 days of overfeeding
Variable Day 0 Day 28 P
Weight (kg) 75.9  12.3 78.6  12.7 0.001
BMI (kg/m
2) 26.0  3.6 26.9  3.7 0.001
Waist (cm) 88.9  10.8 91.4  11.6 0.001
WHR 0.87  0.08 0.87  0.09 0.34
Fat mass (%) 35.8  8.8 36.9  8.5 0.001
Fat cell size (M) 59.2  6.6 58.3  6.5 0.53
Liver fat (Hu) 54.9  11.6 52.6  11.5 0.001
Abdominal fat (kg) 2.0  0.7 2.2  0.7 0.001
Glucose (mmol/l) 4.5  0.4 4.6  0.3 0.01
Fasting insulin (mU/ml) 9.9  3.3 11.4  2.9 0.01
GIR/FFM (mol/kg/min) 54.9  18.7 48.9  15.7 0.01
Total cholesterol (mmol/l) 4.7  1.0 4.9  1.2 0.01
HDL cholesterol (mmol/l) 1.3  0.3 1.4  0.5 0.001
LDL cholesterol (mmol/l) 2.8  0.9 2.8  0.9 0.75
Triglycerides (mmol/l) 1.1  0.4 1.1  0.6 0.89
Data are presented as means  SD. P  0.05 was considered
statistically signiﬁcant. WHR, waist-to-hip ratio.
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cell polarization. Circulating immune cells were also
analyzed by ﬂow cytometry at both visits, with a focus on
cell numbers of major immune cell subsets and on expres-
sion of cell surface activation markers on different sub-
sets. There was no change in relative cell number of
neutrophils, monocytes, and lymphocytes after 28 days of
overfeeding (Fig. 4). Similarly, numbers of CD4 T-helper
cells, including the speciﬁc phenotypes type 1 and type 2,
as well as CD8 cytotoxic T-cells, did not change over the
28-day overfeeding period. Furthermore, expression of
activation markers CD66b, CD62L, and CD11b on neutro-
phils and monocytes, as well as CD69, CD62L, and CD25
on T-cells were not changed by overfeeding (Table 2).
DISCUSSION
Obesity and type 2 diabetes are characterized by the
coexistence of insulin resistance and chronic low-grade
inﬂammation (1). However, it is controversial whether
insulin resistance is a cause or consequence of such
“inﬂammation.” Our study demonstrates that overfeeding
for 28 days in healthy humans results in moderate weight
gain, with signiﬁcant increases in total and abdominal fat
mass and liver fat deposition. In parallel, we observed
increases in fasting insulin and an 11% decrease in periph-
eral insulin sensitivity by hyperinsulinemic clamp. Impor-
tantly, this study is the ﬁrst to show that peripheral insulin
resistance occurred without substantial changes in inﬂam-
matory markers in the circulation or within subcutaneous
adipose tissue in humans as demonstrated using ﬂow
cytometry, immunohistochemistry, and gene expression.
Our data therefore suggest that low-grade systemic and
subcutaneous adipose tissue inﬂammation, macrophage
inﬁltration, and immune activation occur secondary to
weight gain and peripheral insulin resistance in humans.
Interpretation of these ﬁndings is limited to subcutaneous
adipose tissue. The dynamics of the inﬂammatory re-
sponse in other fat depots, particularly visceral adipose
tissue, cannot be addressed in this study.
Inﬂammation has been implicated as a primary factor in
the pathogenesis of insulin resistance and type 2 diabetes
(3,8). This is supported by studies showing associations
between elevated inﬂammatory markers and indexes of
insulin resistance in obese animals and humans (23–25)
and in vitro studies showing that addition of inﬂammatory
cytokines inhibits the insulin signaling cascade (26). More-
over, studies in rodents have shown that there is a rapid
induction of inﬂammatory gene expression in adipose
tissue after HFD (27). Interestingly, Xu et al. also observed
signiﬁcant elevations in MCP-1 gene expression after 3
weeks of HFD, but did not detect changes in macrophage-
speciﬁc markers (F4/80 or CD68) until 16 weeks of HFD
(28). Strissel et al. also performed an elegant temporal
investigation of macrophage inﬁltration and adipocyte
death at 1, 4, 8, 16, and 20 weeks. They observed that
adipocyte hypertrophy preceded adipocyte death and mac-
rophage inﬁltration, which was signiﬁcantly elevated 8
weeks after initiation of HFD as assessed by inﬂammatory
gene expression and F4/80 staining. This increase coin-
cided with impaired responsiveness to insulin, suggesting
a link between macrophage inﬁltration of adipose tissue
and induction of peripheral insulin resistance. However,
the gold standard measure of insulin sensitivity, the hyper-
insulinemic clamp, was not performed in this study and
insulin resistance measured by clamp or by 2-deoxyglu-
cose uptake is impaired as early as 3 weeks after initiation
of HFD in rodents (29,30).
Few studies have prospectively examined the effects of
overfeeding on adipose tissue macrophage inﬁltration in
humans. In the current study, we detected no changes in
subcutaneous adipose tissue macrophages by gene expres-
sion or by histology after 28 days of overfeeding with the
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FIG. 1. Serum levels of inﬂammatory markers. (A) CRP, (B) MCP-1, (C) sICAM-1, and (D) IL-6 levels at baseline (black bars) and 28 days after
overfeeding (open bars). Data are presented as means  SEM. *P < 0.05.
C.S. TAM AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, SEPTEMBER 2010 2167exception of increased CD40/CD206 ratio, but without
signiﬁcant changes in the absolute numbers of CD40 and
CD206 labeled cells and no change in circulating immune
cells. It is possible that the single time point chosen here
was inappropriate to detect substantial changes in macro-
phage inﬁltration. Regardless, 28 days of overfeeding
induced peripheral insulin resistance, supporting the dis-
sociation between macrophage inﬁltration and induction
of insulin resistance in humans. Interestingly, mouse stud-
ies have shown that prevention of inﬂammation by mac-
rophage-speciﬁc knockout of JNK or IKK only provides
partial protection from diet-induced insulin resistance;
that is, the knockouts are more insulin sensitive as com-
pared with wild-types on HFD, but they are still more
insulin resistant as compared with chow-fed animals
(31,32). In humans, future studies to deﬁnitively answer
whether insulin resistance precedes macrophage inﬁltra-
tion could involve more sampling time points or be per-
formed with anti-inﬂammatory agents to determine
whether dampening of the inﬂammatory cascade prevents
insulin resistance during overfeeding in humans.
CRP, a validated inﬂammatory marker secreted by the
liver, is highly correlated with adiposity and rapidly re-
duced by weight loss (33). We observed signiﬁcantly
increased serum CRP at 3 and 28 days of overfeeding and
speculate that this could be due to the increase in liver fat
after overfeeding. Associations have previously been re-
ported between CRP and non-alcoholic fatty liver disease
(NAFLD) (34–36), although we did not observe a correla-
tion between change in CRP and change in liver fat.
Interestingly, serum MCP-1 was also increased after 28
days of overfeeding, despite no detectable changes in
subcutaneous adipose tissue MCP-1 expression, or
HAM56 macrophages, suggesting another source of
MCP-1 (37,38). MCP-1 is involved in the recruitment of
macrophages into adipose tissue (39) and transgenic mice
overexpressing MCP-1 exhibit insulin resistance (39).
CCR2 knockout mice have improved insulin sensitivity,
reduced macrophage content, and reduced inﬂammatory
proﬁle in adipose tissue while on a HFD (40). Previous
studies have shown that adipose MCP-1 mRNA levels
increased within 2–7 days of HFD in mice, with an
elevation in plasma MCP-1 detected after 4 weeks (27).
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FIG. 2. Immunohistochemistry staining of (A) macrophage-speciﬁc
marker (HAM56), M1 marker (CD40), and M2 marker (CD206) pheno-
type macrophages in subcutaneous adipose tissue. Pictures are taken
from paired representative slides, and positive cells are marked with a
black arrow. B: Change in HAM56, CD40, CD206 positive cells from
baseline in response to 28 days of overfeeding. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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FIG. 3. Analysis of stromovascular fraction of subcutaneous adipose
tissue. Relative numbers of endothelial cells (CD34
/CD31
), preadi-
pocytes/CD34
 precursor cells (CD34
/CD31
), macrophages (CD14
)
and expression of activation marker CD11b on macrophages, shown as
rMFI at baseline (black bars) and after 28 days of overfeeding (open
bars). Data are presented as means  SEM. SVF, stromovascular
fraction.
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FIG. 4. Circulating immune cell numbers. Relative cell numbers of
circulating immune cell subsets, expressed as a percentage of total
white blood cells [granulocytes (G), monocytes (M), lymphocytes (L),
or T-cells (T)] or as a percentage of T-lymphocytes (CD4, CD8) or as a
percentage of CD4 T-cells [T-helper cells type 1 (Th1) and type 2
(Th2)] at baseline (black bars) and after 28 days of overfeeding (open
bars). Data are presented as means  SEM.
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MCP-1 in this study may play a role in later recruitment of
macrophages into adipose tissue.
Recent studies have suggested that adipose tissue
inﬁltration by T-lymphocytes is a primary event leading
to subsequent recruitment of macrophages (13–15).
Kintscher et al. demonstrated development of glucose
intolerance and T-cell inﬁltration after 3 weeks of high-fat
feeding but did not observe any changes in adipose tissue
macrophage inﬁltration until 8 weeks of HFD, where there
was signiﬁcant weight gain in mice. Together with other
animal studies (13,15), these results suggest that glucose
intolerance and T-cell activation may be primary events
preceding macrophage inﬁltration and that macrophages
only contribute later to insulin resistance by increased
secretion of cytokines. In the current study, we saw little
evidence of T-cell accumulation in subcutaneous adipose
tissue. Future overfeeding studies in overweight to mor-
bidly obese cohorts will be important for elucidating
immune cell dynamics in adipose tissue in humans.
In conclusion, moderate weight gain after 28 days of
overfeeding in healthy humans resulted in signiﬁcantly
increased body fatness, peripheral insulin resistance, and
increased circulating CRP and MCP-1, without changes in
subcutaneous adipose tissue immune cell histology or
inﬂammatory gene expression. We hypothesized that adi-
pose tissue inﬁltration by macrophages is dynamic and
should occur at the time of fat deposition, if they are
causative in insulin resistance. However, we detected no
increase in the proportion of subcutaneous adipose tissue
macrophages despite signiﬁcant fat deposition and insulin
resistance. These combined ﬁndings support the hypothe-
sis that weight gain-induced insulin resistance from short-
term overfeeding is an early metabolic defect preceding
immune activation and macrophage recruitment into sub-
cutaneous adipose tissue in humans.
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